Accessibility Menu
Avita Medical Stock Quote

Avita Medical (NASDAQ: RCEL)

$4.02
(1.5%)
+0.06
Price as of October 23, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$4.02
Daily Change
(1.5%) +$0.06
Day's Range
$4 - $4.14
Previous Close
$4.02
Open
$4
Beta
1.41
Volume
115,101
Average Volume
650,726
Market Cap
98.4M
Market Cap / Employee
$3.96M
52wk Range
$3.6 - $14.16
Revenue
-
Gross Margin
0.84%
Dividend Yield
N/A
EPS
-$1.97
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Avita Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
RCEL-61.31%-82.94%-29.78%-84%
S&P+14.5%+93.32%+14.09%+377%

Avita Medical Company Info

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$18.42M21.2%
Gross Profit$14.95M14.3%
Gross Margin81.17%-4.9%
Market Cap$131.42M-33.2%
Market Cap / Employee$0.51M0.0%
Employees26025.6%
Net Income-$9.92M35.6%
EBITDA-$10.60M31.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$12.22M-30.0%
Accounts Receivable$11.34M30.1%
Inventory7.512.3%

Liabilities

Q2 2025YOY Change
Long Term Debt$2.37M-94.6%
Short Term Debt$42.22M5048.3%

Ratios

Q2 2025YOY Change
Return On Assets-70.67%-13.4%
Return On Invested Capital-65.05%-29.8%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$10.98M29.1%
Operating Free Cash Flow-$10.45M18.5%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book11.6327.4547.68-30.59-587.81%
Price to Sales4.645.212.981.86-50.57%
Price to Tangible Book Value11.9028.84-200.30-13.96-318.88%
Enterprise Value to EBITDA-20.73-35.98-20.52-15.8925.46%
Return on Equity-152.4%-231.0%-407.5%-935.7%769.12%
Total Debt$45.63M$45.99M$44.07M$44.59M-1.11%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.